OrbiMed Genesis Fund, L.P.
OrbiMed Genesis Fund, L.P. is a hedge fund based in New York, New York. According to its most recent Form D, filed Dec 5, 2025, the fund has sold $353,340,923 of interests to 107 investors since its first sale in Nov 2019. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Carl Gordon; OrbiMed Advisors LLC; Geoffrey Hsu.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
The firm that manages it, Orbimed Advisors LLC, files Form 13F. Its page shows the firm's disclosed stock holdings and an estimate derived from them. Those figures describe the firm as a whole, not this fund.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $353,340,923Cumulative sales reported on Form D
- Investors
- 107
- First sale
- Nov 7, 2019
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Carl Gordon; OrbiMed Advisors LLC; Geoffrey Hsu
- Latest Form D
- Dec 5, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Dec 5, 2025 | Form D/A (amendment) | $353,340,923 | 107 | SEC.gov ↗ |
| Dec 6, 2024 | Form D/A (amendment) | $338,378,900 | 100 | SEC.gov ↗ |
| Dec 8, 2023 | Form D/A (amendment) | $274,970,000 | 76 | SEC.gov ↗ |
| Dec 9, 2022 | Form D/A (amendment) | $265,425,000 | 72 | SEC.gov ↗ |
| Dec 10, 2021 | Form D/A (amendment) | $184,125,000 | 64 | SEC.gov ↗ |
| Dec 11, 2020 | Form D/A (amendment) | $59,275,000 | 24 | SEC.gov ↗ |
| Dec 12, 2019 | Form D | $50,100,000 | 15 | SEC.gov ↗ |
7 Form D filings in the SEC's electronic records (2008 onward), the earliest on Dec 12, 2019. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Vehicles of this fund (2)
| Legal name on Form D | SEC CIK | Location reported | Total raised | Investors | Minimum | Latest Form D |
|---|---|---|---|---|---|---|
| OrbiMed Genesis Fund, L.P. (main vehicle on this page) | 1796304 | New York, New York | $353,340,923 | 107 | $0 | Dec 5, 2025 |
| OrbiMed Genesis Fund, Ltd. | 1808344 | George Town, Grand Cayman, Cayman Islands | $145,947,234 | 20 | $100,000 | Apr 10, 2026 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings carry the same name apart from such vehicle words or a series letter and report the same location or the same adviser, so AltMountain shows them on one page; the details above are those of OrbiMed Genesis Fund, L.P., the vehicle reporting the most raised. Each row is that vehicle's own filing, exactly as filed. The amounts should not be added together, because a feeder's money can also be counted in its master fund. Grouped by AltMountain from the filings; not confirmed by the fund. The CIK links open each vehicle's filings on SEC.gov. Source: SEC Form D filings.
Raise history: OrbiMed Genesis Fund, Ltd.
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 10, 2026 | Form D/A (amendment) | $145,947,234 | 20 | SEC.gov ↗ |
| Apr 11, 2025 | Form D/A (amendment) | $134,853,571 | 18 | SEC.gov ↗ |
| Apr 12, 2024 | Form D/A (amendment) | $134,748,482 | 18 | SEC.gov ↗ |
| Apr 14, 2023 | Form D/A (amendment) | $125,550,001 | 12 | SEC.gov ↗ |
| Apr 14, 2022 | Form D/A (amendment) | $100,550,001 | 12 | SEC.gov ↗ |
| Apr 14, 2021 | Form D/A (amendment) | $29,300,000 | 3 | SEC.gov ↗ |
| Apr 14, 2020 | Form D | $300,000 | 1 | SEC.gov ↗ |
7 Form D filings in the SEC's electronic records (2008 onward), the earliest on Apr 14, 2020. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about OrbiMed Genesis Fund, L.P.
What is the minimum investment for OrbiMed Genesis Fund, L.P.?
OrbiMed Genesis Fund, L.P.'s latest Form D, filed Dec 5, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in OrbiMed Genesis Fund, L.P.?
OrbiMed Genesis Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has OrbiMed Genesis Fund, L.P. raised?
OrbiMed Genesis Fund, L.P. reports $353,340,923 sold from 107 investors on its Form D filed Dec 5, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is OrbiMed Genesis Fund, L.P. based?
OrbiMed Genesis Fund, L.P. is based in New York, New York and is managed by Orbimed Advisors LLC.
When did OrbiMed Genesis Fund, L.P. launch?
OrbiMed Genesis Fund, L.P. reports its first sale in Nov 2019.
Size compared with every hedge fund
Raised more than 75% of the 2,526 hedge funds based in New York, and more than 77% of all 10,140 that report sales.